Leveraging CRISPR: Identification of Essential Proliferation & Trametinib Resistance Mechanisms in Uveal Melanoma

Time: 1:15 pm
day: Day One

Details:

  • Leveraging CRISPR to identify novel genetic dependencies
  • Validation of CRISPR screening hits
  • Using CRISPR screening results to guide pharmacological targeting of essential mechanisms

Speakers: